Sabag Mark
Insider CIK 1721442 · TEVA EVP, International Markets
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-05-01 | 2026-05-04 | 144,180 | $34.99 | $5.04M | 80,760 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-17 | 2026-03-19 | 62,102 | $30.14 | $1.87M | 224,940 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-05 | 2026-03-09 | 15,723 | — | $0 | 47,170 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-05 | 2026-03-09 | 15,723 | — | $0 | 287,042 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 18,601 | — | $0 | 37,202 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 30,385 | — | $0 | 30,385 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 33,512 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 33,512 | — | $0 | 252,718 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 18,601 | — | $0 | 271,319 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 24,900 | — | $0 | 24,901 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 24,900 | — | $0 | 77,728 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-03 | 2026-03-05 | 141,478 | — | $0 | 219,206 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-01-27 | 2026-01-29 | 141,478 | — | $0 | 141,478 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-12-09 | 2025-12-11 | 118,724 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-12-09 | 2025-12-11 | 118,724 | $18.61 | $2.21M | 269,720 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-12-09 | 2025-12-11 | 118,724 | $28.75 | $3.41M | 150,996 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-12-09 | 2025-12-11 | 98,168 | $28.70 | $2.82M | 52,828 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-05-08 | 2025-05-12 | 337,915 | $18.04 | $6.10M | 150,996 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-03-05 | 2025-03-07 | 62,893 | — | $0 | 62,893 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-05 | 2025-03-07 | 23,765 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-05 | 2025-03-07 | 23,765 | — | $0 | 488,911 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 18,601 | — | $0 | 55,803 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 183,169 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 33,512 | — | $0 | 33,512 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 18,601 | — | $0 | 281,977 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 33,512 | — | $0 | 263,376 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 183,169 | — | $0 | 465,146 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-03 | 2025-03-05 | 24,900 | — | $0 | 49,801 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-03 | 2025-03-05 | 24,900 | — | $0 | 229,864 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-02-12 | 2025-02-14 | 177,626 | $16.25 | $2.89M | 204,964 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-01-28 | 2025-01-30 | 183,169 | — | $0 | 183,169 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-05 | 2024-03-07 | 58,133 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-05 | 2024-03-07 | 23,764 | — | $0 | 23,765 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-05 | 2024-03-07 | 58,133 | — | $0 | 482,590 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-03-05 | 2024-03-07 | 100,000 | $13.52 | $1.35M | 382,590 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-05 | 2024-03-07 | 23,764 | — | $0 | 424,457 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-04 | 2024-03-05 | 33,512 | — | $0 | 67,024 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-03-04 | 2024-03-05 | 74,404 | — | $0 | 74,404 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-04 | 2024-03-05 | 33,512 | — | $0 | 400,693 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-03-03 | 2024-03-05 | 24,900 | — | $0 | 74,701 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-03-03 | 2024-03-05 | 24,900 | — | $0 | 367,181 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-02-28 | 2024-03-01 | 20,599 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-02-28 | 2024-03-01 | 20,599 | — | $0 | 342,281 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-01-30 | 2024-02-01 | 58,133 | — | $0 | 58,133 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-05 | 2023-03-07 | 23,764 | — | $0 | 47,529 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-05 | 2023-03-07 | 23,764 | — | $0 | 321,682 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 33,512 | — | $0 | 100,536 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-03-04 | 2023-03-07 | 15,921 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 33,512 | — | $0 | 281,997 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-03-04 | 2023-03-07 | 15,921 | — | $0 | 297,918 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-03-03 | 2023-03-07 | 99,601 | — | $0 | 99,601 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 50,242 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-02-28 | 2023-03-02 | 20,598 | — | $0 | 20,599 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 20,598 | — | $0 | 198,243 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-02-28 | 2023-03-02 | 50,242 | — | $0 | 248,485 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-02-07 | 2023-02-09 | 50,242 | — | $0 | 50,242 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-05 | 2022-03-08 | 23,764 | — | $0 | 71,293 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-05 | 2022-03-08 | 23,764 | — | $0 | 177,645 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-03-04 | 2022-03-08 | 134,048 | — | $0 | 134,048 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 43,358 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-03-04 | 2022-03-08 | 15,920 | — | $0 | 15,921 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 15,920 | — | $0 | 110,523 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-03-04 | 2022-03-08 | 43,358 | — | $0 | 153,881 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-28 | 2022-03-02 | 20,598 | — | $0 | 41,197 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-28 | 2022-03-02 | 20,598 | — | $0 | 94,603 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-02-09 | 2022-02-10 | 15,523 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-02-09 | 2022-02-10 | 15,523 | — | $0 | 74,005 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-02-08 | 2022-02-10 | 43,358 | — | $0 | 43,358 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-05-11 | 2021-05-13 | 37,884 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-05-11 | 2021-05-13 | 37,884 | — | $0 | 58,482 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2021-03-16 | 2021-03-17 | 127,244 | $11.22 | $1.43M | 20,598 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-03-05 | 2021-03-08 | 95,057 | — | $0 | 95,057 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-03-04 | 2021-03-08 | 15,920 | — | $0 | 31,841 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-03-04 | 2021-03-08 | 15,920 | — | $0 | 147,842 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-28 | 2021-03-02 | 20,598 | — | $0 | 61,795 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-28 | 2021-03-02 | 20,598 | — | $0 | 131,922 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-14 | 2021-02-17 | 5,712 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-14 | 2021-02-17 | 5,712 | — | $0 | 111,324 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-02-09 | 2021-02-11 | 37,884 | — | $0 | 37,884 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-02-09 | 2021-02-11 | 15,523 | — | $0 | 15,523 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award | 2021-02-09 | 2021-02-11 | 65,339 | — | $0 | 105,612 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-02-09 | 2021-02-11 | 15,523 | — | $0 | 40,273 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-28 | 2020-03-03 | 82,393 | — | $0 | 82,393 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 19,040 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 5,710 | — | $0 | 5,712 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 19,040 | — | $0 | 19,040 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 5,710 | — | $0 | 24,750 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2020-02-13 | 2020-02-18 | 72,131 | $13.03 | $939.9K | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-02-11 | 2020-02-13 | 19,040 | — | $0 | 19,040 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-09 | 2020-02-11 | 15,523 | — | $0 | 31,046 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-09 | 2020-02-11 | 15,523 | — | $0 | 72,131 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-03-04 | 2019-03-06 | 47,761 | — | $0 | 47,761 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-02-14 | 2019-02-19 | 5,710 | — | $0 | 11,422 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-02-14 | 2019-02-19 | 5,710 | — | $0 | 56,608 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award | 2019-02-12 | 2019-02-14 | 9,381 | — | $0 | 50,898 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-02-15 | 2018-02-20 | 3,000 | $20.52 | $61.6K | 41,517 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2018-02-14 | 2018-02-20 | 2,050 | $18.45 | $37.8K | 44,517 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 46,569 | — | $0 | 46,569 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-02-09 | 2018-02-12 | 118,724 | — | $0 | 118,724 | SEC↗ |